ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.50083
0.00%
Bitcoin
67,570.34
0.13%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) News

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DateTimeSourceHeadlineSymbolCompany
31/05/202406:01GlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
08/05/202406:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
08/05/202406:05GlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
02/05/202406:05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
25/04/202400:00GlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
15/04/202423:00GlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
05/04/202407:00GlobeNewswire Inc.Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusNASDAQ:CRBUCaribou Biosciences Inc
12/03/202408:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBUCaribou Biosciences Inc
12/03/202407:25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRBUCaribou Biosciences Inc
12/03/202407:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
12/03/202407:05GlobeNewswire Inc.Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
06/03/202408:30GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202409:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
23/02/202408:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
16/02/202408:05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
09/02/202409:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
11/01/202408:18Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
10/01/202408:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
10/01/202408:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
09/01/202408:18Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBUCaribou Biosciences Inc
09/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
08/01/202403:00GlobeNewswire Inc.Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024NASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

Your Recent History

BMF
DIIX24Z24
DIIX24Z24 - 11/2024
BITMOT
830233
Imi Serie Vii Mc Nv27 Eur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved